Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SOLUPRED (prednisolone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 01 July 2015
  • Documents : 1
  • History
Listen Listen
Add to my selection
  • Maintien du remboursement dans les mêmes conditions
  • Clinical Benefit
Quote this publication
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SOLUPRED (prednisolone)

Opinions on drugs - Posted on Jul 30 2015

Reason for request

Renouvellement d'inscription

Maintien du remboursement dans les mêmes conditions


Clinical Benefit

Substantial

Le service médical rendu par les spécialités SOLUPRED 1mg/ml, 5 mg et 20 mg reste important dans les indications de l’AMM.


Documents

  • SOLUPRED_01072015_AVIS_CT14057 Xvox

Contact Us

Évaluation des médicaments
  • Contact Us
All our publications
    Anemia and hemoglobinopathies Bronchial diseases Cancers - miscellaneous Central nervous system diseases Drug therapy Ear diseases Endocrine system diseases Esophageal and gastrointestinal diseases Eye diseases Joint and rheumatic diseases Laryngeal diseases Liver diseases Nose and sinus diseases Pain - Inflammation Pulmonary and pleural diseases Skin and connective tissue diseases Transfusions, transplantations

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
qy2cH3cbqdAdrfMv